6.120USD+0.16%Mkt Cap: 42.09M USDP/E: —Last update: 2026-05-26
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical syst…
Industry Peers
Drug Manufacturers - GeneralIndicators:|
Key Statistics
Company
Market Cap42.09M USD
Enterprise Value159.23M USD
Revenue (TTM)30.25M USD
Gross Profit19.65M USD
Net Income (TTM)-358.73M USD
Revenue/Share2.742 USD
Last Price6.120 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees34
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)8.11
PEG—
EV/EBITDA-0.59
EV/Revenue5.26
P/S1.38
P/B-0.20
EPS (TTM)-40.50
EPS (Forward)0.73
52W Range
4.2006% of range34.27
52W High34.27 USD
52W Low4.200 USD
Profitability
Gross Margin64.97%
Oper. Margin-782.02%
EBITDA Margin0.00%
Profit Margin-1185.78%
ROE172.65%
ROA-98.29%
Growth
Revenue Growth-67.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF3.82M USD
CapEx (TTM)733.00K USD
FCF Margin81.26%
FCF Yield58.40%
Net Debt121.56M USD
Net Debt/EBITDA-0.45
Balance Sheet
Debt/Equity-0.60
Current Ratio0.08
Quick Ratio0.05
Book Value/Sh-29.5440 USD
Cash/Share1.561 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:35
Split DateApr 15, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.7.03M
Float5.19M
Insiders17.56%
Institutions13.11%
Short Interest
Short Ratio2.9d
Short % Float3.05%
Short % Out.2.40%
Shares Short169.14K
Short (prev mo.)187.95K
Technical
SMA 507.340 (-16.6%)
SMA 20013.73 (-55.4%)
Beta1.79
S&P 52W Chg28.31%
Avg Vol (30d)88.31K
Avg Vol (10d)72.44K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—